Relay Therapeutics, Inc. (RLAY) Misses Q3 EPS by 1c

Relay Therapeutics, Inc. (NASDAQ: RLAY) reported Q3 EPS of ($0.43), $0.01 worse than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Relay Therapeutics, Inc. (RLAY) click here.

You May Also Be Interested In

• Anthropic Signs $35b Cloud Deal With Lambda In Texas: WSJ
• Hyper Bit Technologies Announces Closing of Private Placement
• PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short